Improved 24-hour plasma glucose profile in patients with type 2 diabetes treated with Humalog® Mix25™

被引：0
|
作者：
Herz, M
Arora, V
Mollentze, W
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [31] Analysis of 24-Hour Glycemic Excursions in Patients with Type 1 Diabetes by Using Continuous Glucose Monitoring
    Taki, Kentaro
    Nishimura, Rimei
    Morimoto, Aya
    Tsujino, Daisuke
    Miyashita, Yumi
    Tajima, Naoko
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (07) : 523 - 528
  • [32] Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits
    Coscelli, C
    Iacobellis, G
    Calderini, C
    Carleo, R
    Gobbo, M
    Di Mario, U
    Leonetti, F
    Galluzzo, A
    Pirrone, V
    Lunetta, M
    Casale, P
    Paleari, F
    Falcelli, C
    Valle, D
    Camporeale, A
    Merante, D
    ACTA DIABETOLOGICA, 2003, 40 (04) : 187 - 192
  • [33] Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits
    C. Coscelli
    G. Iacobellis
    C. Calderini
    R. Carleo
    M. Gobbo
    U. Di Mario
    F. Leonetti
    A. Galluzzo
    V. Pirrone
    M. Lunetta
    P. Casale
    F. Paleari
    C. Falcelli
    D. Valle
    A. Camporeale
    D. Merante
    Acta Diabetologica, 2003, 40 : 187 - 192
  • [34] Humalog™ Mix25 (25%NPL:75%Lispro) is a safe and effective alternative to human insulin 30/70 (30%R:70%NPH) in the treatment of type 2 elderly diabetes
    Matto, V
    Malone, J
    Tiku, A
    Dhungel, S
    Fernando, D
    Mohan, V
    Sethi, B
    Yajnik, C
    Bansal, S
    DIABETES, 2003, 52 : A452 - A452
  • [35] Interrupted sitting improves 24-hour glucose control in people with type 1 diabetes
    Campbell, M.
    Dingena, C.
    Marsh, A.
    Coales, E.
    O'Mahoney, L.
    Dempsey, P.
    Francois, M.
    Ajjan, R.
    Alobaid, A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S197 - S198
  • [36] Profiles of Patients with Type 2 Diabetes Needing 1 to 3 Injections of Insulin Lispro Mix25 in PARADIGM Study
    Bowering, Keith
    Cao, Dachuang
    Felicio, Joao
    Ji, Linong
    Schmitt, Henry
    Bhattacharya, Indranil
    Jabbar, Abdul
    DIABETES, 2017, 66 : A615 - A615
  • [37] Effect of Sitagliptin on 24-Hour Glycemic Variations in Japanese Patients with Type 2 Diabetes as Assessed by Continuous Glucose Monitoring (CGM)
    Taniguchi, Yukiko
    Mori, Yutaka
    Matsuura, Kenichi
    Itoh, Yohta
    Sezaki, Kazunori
    Yokoyama, Junichi
    Tajima, Naoko
    DIABETES, 2010, 59 : A558 - A558
  • [38] Humalog® and Humalog Mix50® provide better glycemic control than Lantus® in patients with type 2 diabetes
    Kazda, CM
    Huelstrunk, H
    Helsberg, K
    Langer, F
    Forst, T
    DIABETES, 2004, 53 : A131 - A131
  • [39] Empagliflozin Improves 24-Hour Blood Pressure Profiles in Patients With Type 2 Diabetes and Hypertension
    Tikkanen, Ilkka
    Narko, Kirsi
    Zeller, Cordula
    Green, Alexandra
    Salsali, Afshin
    Broedl, Uli C.
    Woerle, Hans J.
    CIRCULATION, 2013, 128 (22)
  • [40] Correlation between 24-Hour Urinary Electrolyte and Urinary Albumin in Patients with Type 2 Diabetes
    Wang, Yanru
    Zhang, Mengyu
    Li, Hong
    Qu, Shen
    DIABETES, 2021, 70
12345